Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: Reuters Investment Profile
Provider: Sadif Analytics Prime
Provider: Wright Reports

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Lotus Pharmaceutical Co Ltd to acquire 95 pct of Alvogen Asia Ltd

Thursday, 16 Jan 2014 01:37am EST 

Lotus Pharmaceutical Co Ltd:Says plan of acquiring a 95 pct stake in Alvogen Asia Ltd, a China-based company, to increase sales in Mainland China.Says expected transaction amount of $8.256 million. 

Company Quote

-2.3 -2.44%
1:02am EDT